A comprehensive understanding of how PIK3R1 mutations affect their interactions and regulatory functions will aid in identifying cancer-associated mutations that dysregulate the PI3K pathway and pinpoint the most effective therapeutic targets for inhibitor therapy 3. Here, PIK3R1 is linked to cancer.